Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sherman

Showing results (881-890 of 935) with videos related to

Pageof 94
Sort By:
Journal of the National Cancer Institute|April 5, 2017
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring SurvivalAhmedin Jemal, Elizabeth M Ward, Christopher J Johnson, et al.
G3 (Bethesda, Md.)|July 22, 2015
Genome-Wide Association Study of Down Syndrome-Associated Atrioventricular Septal DefectsDhanya Ramachandran, Zhen Zeng, Adam E Locke, et al.
Cancer|September 21, 2016
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neckAntonio Jimeno, Marshall R Posner, Lori J Wirth, et al.
Journal of Global Health|August 6, 2022
Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society surveyHalder Pinku, Anke Hüls, Patrick T Feany, et al.
Cancer|March 13, 2020
Annual report to the nation on the status of cancer, part I: National cancer statisticsS Jane Henley, Elizabeth M Ward, Susan Scott, et al.
Molecular Genetics & Genomic Medicine|July 19, 2022
Descriptive analysis of seizures and comorbidities associated with fragile X syndromeIgor Albizua, Krista Charen, Lisa Shubeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseE L Sievers, R A Larson, E A Stadtmauer, et al.
Journal of Medical Genetics|June 14, 2022
The International Fragile X Premutation Registry: building a resource for research and clinical trial readinessDavid Hessl, Hilary Rosselot, Robert Miller, et al.
Neuron|June 12, 2003
Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilizationFumiaki Saito, Steven A Moore, Rita Barresi, et al.
The Oncologist|July 27, 2021
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS StudyJohn R Zalcberg, Michael C Heinrich, Suzanne George, et al.
Pageof 94

Showing results (881-890 of 935) with videos related to

Sort By:
Pageof 94
Journal of the National Cancer Institute|April 5, 2017
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring SurvivalAhmedin Jemal, Elizabeth M Ward, Christopher J Johnson, et al.
G3 (Bethesda, Md.)|July 22, 2015
Genome-Wide Association Study of Down Syndrome-Associated Atrioventricular Septal DefectsDhanya Ramachandran, Zhen Zeng, Adam E Locke, et al.
Cancer|September 21, 2016
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neckAntonio Jimeno, Marshall R Posner, Lori J Wirth, et al.
Journal of Global Health|August 6, 2022
Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society surveyHalder Pinku, Anke Hüls, Patrick T Feany, et al.
Cancer|March 13, 2020
Annual report to the nation on the status of cancer, part I: National cancer statisticsS Jane Henley, Elizabeth M Ward, Susan Scott, et al.
Molecular Genetics & Genomic Medicine|July 19, 2022
Descriptive analysis of seizures and comorbidities associated with fragile X syndromeIgor Albizua, Krista Charen, Lisa Shubeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseE L Sievers, R A Larson, E A Stadtmauer, et al.
Journal of Medical Genetics|June 14, 2022
The International Fragile X Premutation Registry: building a resource for research and clinical trial readinessDavid Hessl, Hilary Rosselot, Robert Miller, et al.
Neuron|June 12, 2003
Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilizationFumiaki Saito, Steven A Moore, Rita Barresi, et al.
The Oncologist|July 27, 2021
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS StudyJohn R Zalcberg, Michael C Heinrich, Suzanne George, et al.
Pageof 94